Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Completion of the USFDA Inspection at the Cuddalore Facility of the Company.07-08-2023
07-08-2023
Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Resignation of Director
Pursuant to Regulation 30 of SEBI (LODR), 2015 we wish to inform that Mr. Aditya Puri has resigned from the position of Chairman and Non-Executive Director of the Company with effect from August 5, 2023. Also, Mrs. Vineeta Rai has resigned from the position of Non-Executive Independent Director of the company with effect from August 5, 2023.05-08-2023
Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, kindly note that the Company, as part of investors engagement activities, has scheduled a conference call with the investors and analysts on Friday, August 11, 2023, at 3:30 pm IST to discuss its Q1 financial results.04-08-2023
Solara Active Pharma Sciences Ltd - 541540 - Board Meeting Intimation for Announcement Of Board Meeting Under Regulation 29 Of SEBI Listing Regulations
Solara Active Pharma Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2023 ,inter alia, to consider and approve the un-audited financial results (standalone and consolidated) of the Company for the quarter ended June 30, 2023, amongst other matters.04-08-2023
Solara Active Pharma Sciences Ltd - 541540 - Change In Senior Management
Intimation under Regulation 30 of SEBI (LODR) with respect to change in Senior Management Personnel.01-08-2023
Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015 we wish to inform that Mr. S Hariharan has resigned from the position of Executive Director and CFO of the Company from closure of business hours on July 31, 2023.31-07-2023
Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Resignation of Director
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015 read with Para A of Part A of Schedule III to the said Regulations this is to inform that Mr. Nirmal P Bhogilal (DIN: 00173168) has resigned from the position of Non-Executive Independent Director of the company with effect from July 19, 2023, due to pre-occupation. Consequent to the resignation of Mr. Nirmal P Bhogilal, the Nomination & Remuneration Committee and Stakeholders Relationship Committee have been Re-constituted.19-07-2023
Solara Active Pharma Sciences Ltd - 541540 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
In Compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we are forwarding herewith a copy of certificate received from M/s Cameo Corporate Services Limited, the RTA of the Company, for the quarter ended June 30, 2023 for your records.12-07-2023
Solara Active Pharma Science gains on board nod to raising up to Rs 450 crore
Solara Active Pharma Science plans to issue equity shares with a face value of Rs 10 each, totalling up to Rs 450 crore, including premium06-07-2023
Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Change in Directorate
Pursuant to Regulation 30 Part A, Schedule III of SEBI (LODR) Regulations, 2015, we wish to inform you that the Board of Directors of the Company has approved the changes in directorate and Key Managerial Personnel at its meeting held on July 5, 2023.05-07-2023